Iovance’s AMTAGVI^™ (lifileucel) Receives US FDA Accelerated Approval for Advanced Melanoma

Iovance Biotherapeutics, Inc. announced that the US FDA has approved AMTAGVI™ (lifileucel) suspension for intravenous infusion.